EUVIMEDEUVIMED entdecken
Open Access

The Synergism of Human Lactobacillaceae and Inulin Decrease Hyperglycemia via Regulating the Composition of Gut Microbiota and Metabolic Profiles in db/db Mice

Peifan Li, Tong Tong, Yusong Wu, Xin Zhou, Michael Zhang, Jia Liu, Yongxin She, Zuming Li, Yongli Li

Journal of Microbiology and Biotechnology · 2023

DOI: 10.4014/jmb.2304.04039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2023. Verfasst von Peifan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Biochemical Engineering, Beijing Union University, Beijing, 100023, P.R. China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrointestinal Microbiome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Beijing Municipality, Beijing Union University, Sino Canada health engineering research institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the effects of Limosilactobacillus fermentum and Lactiplantibacillus plantarum isolated from human feces coordinating with inulin on the composition of gut microbiota and metabolic profiles in db/db mice. These supplements were administered to db/db mice for 12 weeks. The results showed that the Lactobacillaceae coordinating with inulin group (LI) exhibited lower fasting blood glucose levels than the model control group (MC). Additionally, LI was found to enhance colon tissue and increase the levels of short-chain fatty acids. 16S rRNA sequencing revealed that the abundance of Corynebacterium and Proteus, which were significantly increased in the MC group compared with NC group, were significantly decreased by the treatment of LI that also restored the key genera of the Lachnospiraceae_NK4A136_group, Lachnoclostridium, Ruminococcus_gnavus_group, Desulfovibrio, and Lachnospiraceae_UCG-006. Untargeted metabolomics analysis showed that lotaustralin, 5-hydroxyindoleacetic acid, and 13(S)-HpODE were increased while L-phenylalanine and L-tryptophan were decreased in the MC group compared with the NC group. However, the intervention of LI reversed the levels of these metabolites in the intestine. Correlation analysis revealed that Lachnoclostridium and Ruminococcus_gnavus_group were negatively correlated with 5-hydroxyindoleacetic acid and 13(S)-HpODE, but positively correlated with L-tryptophan. 13(S)-HpODE was involved in the "linoleic acid metabolism". L-tryptophan and 5-hydroxyindoleacetic acid were involved in "tryptophan metabolism" and "serotonergic synapse". These findings suggest that LI may alleviate type 2 diabetes symptoms by modulating the abundance of Ruminococcus_gnavus_group and Lachnoclostridium to regulate the pathways of "linoleic acid metabolism", "serotonergic synapse", and" tryptophan metabolism". Our results provide new insights into prevention and treatment of type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeHydroxyindoleacetic AcidLinoleic AcidsHumansMiceAnimalsTryptophanMetabolomeRNA, Ribosomal, 16SLactobacillaceaeInulinEubacteriales

Stichwörter der Autor:innen

Human Lactobacillaceaegut microbiotainulinmetabolomicstype 2 diabetes mellitus

Substanzen

InulinTryptophanHydroxyindoleacetic AcidRNA, Ribosomal, 16SLinoleic Acids

Autor:innen und Institutionen

  • College of Biochemical Engineering, Beijing Union University, Beijing, 100023, P.R. China.
  • Department of Physics and Astronomy, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
  • Sino Canada health engineering research institute, Hefei, P.R. China.
  • Internal Trade Food Science and Technology (Beijing) Co., Ltd, Beijing, 102209, P.R. China.
  • Institute of Quality Standard and Testing Technology for Agro-Products, Chinese Academy of Agricultural Science, Beijing, P.R. China.
  • Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, P.R. China.

Förderung

  • Natural Science Foundation of Beijing Municipality
  • Beijing Union University
  • Sino Canada health engineering research institute
  • Internal trade food science and technology (Beijing) Co.

Zitieren

APA

Li, P., Tong, T., Wu, Y., Zhou, X., Zhang, M., Liu, J., She, Y., Li, Z., & Li, Y. (2023). The Synergism of Human Lactobacillaceae and Inulin Decrease Hyperglycemia via Regulating the Composition of Gut Microbiota and Metabolic Profiles in db/db Mice. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2304.04039

Vancouver

Li P, Tong T, Wu Y, Zhou X, Zhang M, Liu J, et al. The Synergism of Human Lactobacillaceae and Inulin Decrease Hyperglycemia via Regulating the Composition of Gut Microbiota and Metabolic Profiles in db/db Mice. Journal of Microbiology and Biotechnology. 2023. doi:10.4014/jmb.2304.04039

BibTeX
@article{Li2023,
  author = {Li, Peifan and Tong, Tong and Wu, Yusong and Zhou, Xin and Zhang, Michael and Liu, Jia and She, Yongxin and Li, Zuming and Li, Yongli},
  title = {The Synergism of Human Lactobacillaceae and Inulin Decrease Hyperglycemia via Regulating the Composition of Gut Microbiota and Metabolic Profiles in db/db Mice},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2023},
  doi = {10.4014/jmb.2304.04039}
}
Kostenlos starten →